Published in Cardiovascular Week, June 6th, 2005
According to the report from Switzerland, "Guidelines for the prevention and treatment of hyperlipidemia are often based on trials using combined clinical end points. Mortality data are the most reliable data to assess efficacy of interventions. We aimed to assess efficacy and safety of different lipid-lowering interventions based on mortality data."
M. Studer and colleagues of the University Hospital in Basel explained, "We conducted a systematic search of randomized controlled trials published up to June 2003, comparing any lipid-lowering intervention...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.